Viewing data from:

TETRABENAZINE

ANDA

TETRABENAZINE | A208826 | BIONPHARMA INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: XENAZINE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$1.30

per ea

Lowest NADAC/Unit

$0.6740

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69452011821TETRABENAZINE 25 MG TABLET	$1.30	EA	Generic	—	2026-10-21
69452011721TETRABENAZINE 12.5 MG TABLET	$0.6740	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain12 active DMFs

11 active API suppliers hold Drug Master Files for this ingredient.

CORDEN PHARMA CHENOVETETRABENAZINE

DMF 166832003

CHEMWERTH INCTETRABENAZINE(NON-STERILE BULK DRUG SUBSTANCE)

DMF 249462011

HETERO DRUGS LTDTETRABENAZINE

DMF 261132012

CENTAUR PHARMACEUTICALS PVT LTDTETRABENAZINE

DMF 263082012

APOTEX PHARMACHEM INDIA PVT LTDTETRABENAZINE

DMF 271352013

MATRIX PHARMACORP PRIVATE LTDTETRABENAZINE

DMF 271472013

SUN PHARMACEUTICAL INDUSTRIES LTDTETRABENAZINE

DMF 271862013

MATRIX PHARMACORP PRIVATE LTDTETRABENAZINE

DMF 281942014

ROLABO OUTSOURCING SLTETRABENAZINE

DMF 298282015

PIRAMAL PHARMA LTDTETRABENAZINE

DMF 324502018

INKE SATETRABENAZINE

DMF 372182022

AGNO PHARMATETRABENAZINE

DMF 401142024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 12.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 18, 2017

No patent or exclusivity listings for this strength.

#002 — 25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 18, 2017